2016 Hematological Malignancies

HD15 in advanced HL Overall Survival (OS @ 5yrs)

Overall Survival 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 0

A: 91.9% B: 95.3% C: 94.5%

p-value

60 months difference

A vs. B : 0.02 A vs. C : 0.07 C vs. B : 0.6

3.3% 2.6% 0.7%

97.5%-CI: [ 0.2%, 6.5%]

[-0.6%, 5.9%] [-2.1%, 3.5%]

12

24

36

48

60

72

Time [months]

Engert A et al, Lancet 2012